Scleroderma, Systemic
Immunology·MeSH: Scleroderma, Systemic
Prevalence
200.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Scleroderma, Systemic?
There are 2 clinical trials targeting Scleroderma, Systemic tracked by BioSniper.
What is the prevalence of Scleroderma, Systemic?
The estimated prevalence of Scleroderma, Systemic is approximately 200.0 per 100,000 population.
Deep-dive into Scleroderma, Systemic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis